LUMINA PHARMACEUTICALS
Live / Allowed — Published for opposition (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99144291
- Mark type
- Design + words
- Filed
- 18 Apr 2025
- Published for opposition
- 31 Mar 2026
- Attorney of record
- Megan E. Fink
Goods and services
- Class 005 — Pharmaceuticals: Radioactive pharmaceutical preparations for exclusive use in vivo diagnostic or therapeutic use, none of the foregoing being substances injected for dermal use or substances affecting metabolism or related to medical wound dressings or for use in the treatment of immunological or dermatological diseases or disorders
Owner
- Lumina Pharmaceuticals Inc., Wilmington, DE, US
- Lumina Pharmaceuticals Inc., Wilmington, DE, US
Prosecution history
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 10 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 10 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 09 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Mar 2026 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 09 Mar 2026 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 09 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Jan 2026 — NON-FINAL ACTION E-MAILED